Professor Paul Kelly is the Australian Government’s Chief Medical Officer. He is a public health physician and epidemiologist who has been a researcher, health systems developer, post-graduate teacher and a health executive in Australia and internationally. He has advised the Commonwealth Government and the National Cabinet during the COVID-19 pandemic.

Professor Eric Chow is a sexual health epidemiologist at Monash University and Melbourne Sexual Health Centre. His research program aims to improve the treatment, prevention and control of sexually transmitted infections (STI), with a particular focus on gonorrhoea and human papillomavirus.

Jo-Anne Dillon’s research interests include the antimicrobial susceptibility, molecular epidemiology, and biology of Neisseria gonorrhoeae. She co-founded the WHO-GASP program and is currently the President of IUSTI. She is a Distinguished Professor at the University of Saskatchewan.

Michael Marks is Professor of Medicine at LSHTM and an Honorary Consultant in Infectious Diseases at the Hospital for Tropical Diseases, University College London Hospital. His major area of interest has been the epidemiology and control of Treponema pallidum including using next-generation sequencing approaches, evaluating Linezolid as a new oral therapy for syphilis investigating integrating near-patient diagnostics for STIs into antenatal care in Zimbabwe.

Dr. Troy Grennan an infectious diseases physician and researcher in Vancouver, Canada, whose work focuses on HIV/STI treatment and prevention, and LGBTQ+ health. Dr. Grennan is Vice-Chair of the Public Health Agency of Canada’s National Advisory Committee on STI, and Co-Principal Investigator of the DISCO study, a Canadian clinical trial examining of doxyPEP and doxyPrEP.